US Patent 11642398 Factor IX polypeptide formulations
Patent 11642398 was granted and assigned to Bioverativ on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Mark Brader0
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+146 characters)
US Patent 11642398 Factor IX polypeptide formulations
Article
The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116423980
Date of Patent
May 9, 2023
0Patent Application Number
167736340
Date Filed
January 27, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11642398 Factor IX polypeptide formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
